Fundz

Site One Therapeutics, Inc. reported raising $14.9 Million in an initial SEC Form D filing, from an offering of $15.1 Million

PRIVATEFeb 14, 2017$14.9M of $15.1M raised

Amount Raised

$14.9 Million

$14.9 Million sold, per SEC Form D (first sale Feb 14, 2017)

Round Type

Venture

South San FranciscoBiotechnologyHealthcare

Quick answer

SiteOne Therapeutics raised $14.9 Million in a funding round, dated February 14, 2017. SiteOne Therapeutics is based in South San Francisco, California, United States.

How much did SiteOne Therapeutics raise?
SiteOne Therapeutics raised $14.9 Million in a funding round on February 14, 2017.
What does SiteOne Therapeutics do?
SiteOne Therapeutics, Inc. is a biopharmaceutical company developing selective ion channel modulators aimed at treating conditions such as pain and cough.
Where is SiteOne Therapeutics based and how big is it?
SiteOne Therapeutics is based in South San Francisco, California, United States.
Who are the decision-makers at SiteOne Therapeutics?
Fundz holds 1 contact at SiteOne Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as SiteOne Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • AliveCor, Inc. raised $30M on March 30, 2017.
  • Streamex Corp. raised an undisclosed amount on March 30, 2017.
  • MetaVia raised $13M on March 30, 2017.
  • iSpecimen raised $500K on March 29, 2017.
  • Cardiol Therapeutics Inc. raised $56K (Pre-Seed) on March 29, 2017.
  • XTL Biopharmaceuticals Ltd raised $2.8M (Seed) on March 29, 2017.

Who to call at SiteOne Therapeutics, and when

A new round usually means SiteOne Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day SiteOne Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SiteOne Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SiteOne Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SiteOne Therapeutics

Location

280 Utah Ave., Suite 250

South San Francisco, California, United States

About

SiteOne Therapeutics, Inc. is a biopharmaceutical company developing selective ion channel modulators aimed at treating conditions such as pain and cough. The company's focus is on creating non-opioid treatments that target sensory hyperexcitability disorders. Their lead program targets the NaV1.8 channel, with a focus on providing effective analgesia while minimizing side effects and abuse potential. SiteOne's innovative approach prioritizes the development of therapeutics that directly affect the peripheral nervous system.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SiteOne Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for SiteOne Therapeutics's next move

See what Strategic adds

SiteOne Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.